
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+27
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngenes more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as...
Drug discovery,drug development,drug manufacturing,small molecules,biologics,integrated drug discovery,peptides,oligonucleotides,antibody drug conjugates,protacs,rare and orphan drugs,car-t,pdna & mrna,central compound management,discovery chemistry,discovery biology,safety assessment,computational & data sciences,chemical development,formulation development,clinical development,analytical development,commercial manufacturing,sterile fill-finish,molecular biology,protein sciences,cell line development & analysis,antibody generation,analytical characterization & quality control,viral testing & clearance,bioanalytical laboratory services,and mammalian gene to gmp
Syngene international limited operates in the Research services industry.
Syngene international limited's revenue is 101m - 500m
Syngene international limited has 5001 - 10000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.